You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Development and validation of therapy for mucopolysaccharidosis III
SBC: Phoenix Nest Inc. Topic: 103Project Summary Sanfilippo disease (mucopolysaccharidosis type III; MPS III) is a devastating neurodegenerative lysosomal storage disorder of childhood whose pathologic features are neurologic: slowing of development, severe behavioral problems, progressive cognitive decline, dementia, and decline in motor skills leading to immobility, unresponsiveness, and death. We have focused on MPS IIID cause ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Validation of a salivary miRNA diagnostic test for autism spectrum disorder
SBC: Quadrant Biosciences Inc. Topic: 103Autism spectrum disorder (ASD) is a continuum of neurodevelopmental characteristics that includes deficits in communication and social interaction, as well as restrictive, repetitive interests and behaviors. ASD is an increasing public health concern, with about 1 in 45 American children diagnosed with ASD in 2014, a 10-fold increase in prevalence over the past 40 years. The effect of ASD on both ...
STTR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
V-Motive: System for Comprehensive Therapy-Integrated Video Modeling
SBC: Experiad LLC Topic: 104DESCRIPTION (provided by applicant): This fast-track SBIR will result in a new type of software system, called V-Motive, which will facilitate the combination of two proven autism behavioral interventions: Applied Behavior Analysis therapy (ABA) and Video Modeling (VM). V-Motive will have the potential to change how ABA therapy is performed by making it feasible for therapy providers to leverage V ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Painless Defibrillation
SBC: Coridea, LLC Topic: NHLBIProject SummaryThe purpose of the proposed work is first-in-man testing of novel painless defibrillation (PaDe) therapy. Sudden cardiac arrest (SCA) remains the number one killer in western civilization. The underlying mechanism of SCA is usually ventricular fibrillation (VF), and survival depends on prompt defibrillation. Existing defibrillators rely on the delivery of a brief high voltage shock ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Development of Anti-ceramide scFv as Mitigator of the Radiation GI Syndrome
SBC: Ceramedix Holding, LLC Topic: NIAIDProject Summary/Abstract Inhibition of ceramide protects mice from death from the Radiation GI Syndrome (RGS). Administration of anti- ceramide single-chain Fv (scFv) 24 h post radiation exposure increases survival in intestinal stem cells and dramatically improves overall survival in mice. These data indicate that anti-ceramide scFv represents the first effective mitigator of lethal RGS. To advan ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Splice sensors for cancer drug discovery
SBC: LUCERNA INC Topic: 102SUMMARY: RNA splicing plays a central role in the generation of proteome diversity and in gene regulation. Splicing impacts vital cellular processes, such as cell-fate and differentiation, acquisition of tissue-identity, and organ development. Thus, defects in splicing has been linked to many diseases, including spinal muscular atrophy, Duchenne muscular dystrophy, Parkinson’s disease, and sever ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Advanced Dynamic Clamp for Neuroscience
SBC: Cytocybernetics Inc Topic: 101The goal of this proposal is to develop a commercial “plug and play”, user-friendly, powerful and reliable dynamic clamp system, to enable all neuronal electrophysiologists to be able to perform sophisticated dynamic clamp experiments, without any requirement for programming, engineering, or mathematical modeling skills. We will develop hardware and software specifically for neuroscience appli ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Minimally Invasive Cardiac Sympathetic Denervation for Malignant Ventricular Arrhythmia
SBC: Coridea, LLC Topic: NHLBISympathetic innervation of the heart plays a critical role in arrhythmogenesis and recent studies have highlighted the role of surgical sympathetic denervation in management of refractory ventricular arrhythmiasThe procedure although safe is very invasive and performed via thoracoscopy using single lung ventilationThis is not tolerated by patients with lung disease or severe structural heart disea ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Expressive Speech Synthesis for Speech-Generating Devices
SBC: SYNFONICA LLC Topic: NIDCDProject SummaryThe expression of emotions through speech is an essential element of human communicationyet individuals with speech impairments who rely on speech generating devicesSGDsto talk are largely deprived of this communicative channelNo one should be forced to sound blaswhen in fact they re elated or to sound apathetic when they intend to scoldWhile certain expressive speech modes are offe ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Business Potential of a Novel Small Animal Model and its Single-Chain Antibodies
SBC: INGENIOUS TARGETING LABORATORY INC. Topic: NIAIDProject Summary Genetically-modified mouse models have proven to be essential for the production of antibody-related biological drugs (biologics). To date, the majority of biologics originate from mouse models, and small animal models are used not only to generate the antibodies, but also as a platform for further optimization and testing of the biologics. Unmet Need: Camelid-based antibodies, whi ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health